
Brian E. Mcdowell
Examiner (ID: 5411, Phone: (571)270-5755 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 4161, 1624 |
| Total Applications | 1663 |
| Issued Applications | 1042 |
| Pending Applications | 129 |
| Abandoned Applications | 533 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11627214
[patent_doc_number] => 20170137402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1'
[patent_app_type] => utility
[patent_app_number] => 15/322277
[patent_app_country] => US
[patent_app_date] => 2015-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35590
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15322277
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/322277 | Inhibitors of lysine specific demethylase-1 | Jun 25, 2015 | Issued |
Array
(
[id] => 11480401
[patent_doc_number] => 09586929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-07
[patent_title] => '6-, 7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 14/749448
[patent_app_country] => US
[patent_app_date] => 2015-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41238
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14749448
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/749448 | 6-, 7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same | Jun 23, 2015 | Issued |
Array
(
[id] => 10483236
[patent_doc_number] => 20150368255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'HALOGENATED INDOLE AND BENZOFURAN DERIVATIVES OF ISOQUINUCLIDENE AND PROCESSES FOR PREPARING THEM'
[patent_app_type] => utility
[patent_app_number] => 14/741134
[patent_app_country] => US
[patent_app_date] => 2015-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6603
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14741134
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/741134 | Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them | Jun 15, 2015 | Issued |
Array
(
[id] => 11604021
[patent_doc_number] => 20170121322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'BET-PROTEIN INHIBITING 3,4-DIHYDROPYRIDO[2,3-B]PYRAZINONES WITH META-SUBSTITUTED AROMATIC AMINO- OR ETHER GROUPS'
[patent_app_type] => utility
[patent_app_number] => 15/317925
[patent_app_country] => US
[patent_app_date] => 2015-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45830
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317925
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/317925 | BET-PROTEIN INHIBITING 3,4-DIHYDROPYRIDO[2,3-B]PYRAZINONES WITH META-SUBSTITUTED AROMATIC AMINO- OR ETHER GROUPS | Jun 14, 2015 | Abandoned |
Array
(
[id] => 10381825
[patent_doc_number] => 20150266832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'MEGLUMINE SALT OF 6-FLUORO-3-HYDROXY-2-PYRAZINE CARBOXAMIDE'
[patent_app_type] => utility
[patent_app_number] => 14/734263
[patent_app_country] => US
[patent_app_date] => 2015-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11587
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14734263
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/734263 | MEGLUMINE SALT OF 6-FLUORO-3-HYDROXY-2-PYRAZINE CARBOXAMIDE | Jun 8, 2015 | Abandoned |
Array
(
[id] => 10381824
[patent_doc_number] => 20150266831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'SODIUM SALT OF 6-FLUOR0-3-HYDROXY-2-PYRAZINE CARBOXAMIDE'
[patent_app_type] => utility
[patent_app_number] => 14/733199
[patent_app_country] => US
[patent_app_date] => 2015-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9866
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14733199
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/733199 | SODIUM SALT OF 6-FLUOR0-3-HYDROXY-2-PYRAZINE CARBOXAMIDE | Jun 7, 2015 | Abandoned |
Array
(
[id] => 12346671
[patent_doc_number] => 09951060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => 2-acylaminothiazole derivative or salt thereof
[patent_app_type] => utility
[patent_app_number] => 15/316645
[patent_app_country] => US
[patent_app_date] => 2015-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23960
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316645
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316645 | 2-acylaminothiazole derivative or salt thereof | Jun 4, 2015 | Issued |
Array
(
[id] => 14261265
[patent_doc_number] => 10280184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Heterocyclic kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/304131
[patent_app_country] => US
[patent_app_date] => 2015-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39389
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304131
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/304131 | Heterocyclic kinase inhibitors | Apr 15, 2015 | Issued |
Array
(
[id] => 17236610
[patent_doc_number] => 11180481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Oxopiperazine helix mimetics as inhibitors of the p53-MDM2 interaction
[patent_app_type] => utility
[patent_app_number] => 15/304490
[patent_app_country] => US
[patent_app_date] => 2015-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 36
[patent_no_of_words] => 19450
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1636
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15304490
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/304490 | Oxopiperazine helix mimetics as inhibitors of the p53-MDM2 interaction | Apr 14, 2015 | Issued |
Array
(
[id] => 10399332
[patent_doc_number] => 20150284340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY'
[patent_app_type] => utility
[patent_app_number] => 14/687174
[patent_app_country] => US
[patent_app_date] => 2015-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 54844
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14687174
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/687174 | QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY | Apr 14, 2015 | Abandoned |
Array
(
[id] => 10620575
[patent_doc_number] => 09339501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => '17a-hydroxylase/C17,20-lyase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/682504
[patent_app_country] => US
[patent_app_date] => 2015-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33334
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14682504
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/682504 | 17a-hydroxylase/C17,20-lyase inhibitors | Apr 8, 2015 | Issued |
Array
(
[id] => 10406646
[patent_doc_number] => 20150291655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/682179
[patent_app_country] => US
[patent_app_date] => 2015-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 91916
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14682179
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/682179 | Triterpenoids with HIV maturation inhibitory activity | Apr 8, 2015 | Issued |
Array
(
[id] => 10395142
[patent_doc_number] => 20150280149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'FUSING PORPHYRINS WITH POLYCYCLIC AROMATIC HYDROCARBONS AND HETEROCYCLES FOR OPTOELECTRONIC APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/678007
[patent_app_country] => US
[patent_app_date] => 2015-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 15759
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14678007
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/678007 | FUSING PORPHYRINS WITH POLYCYCLIC AROMATIC HYDROCARBONS AND HETEROCYCLES FOR OPTOELECTRONIC APPLICATIONS | Apr 2, 2015 | Abandoned |
Array
(
[id] => 12158764
[patent_doc_number] => 20180030030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'AMIDE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 15/127574
[patent_app_country] => US
[patent_app_date] => 2015-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11362
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15127574
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/127574 | Amide compound | Mar 24, 2015 | Issued |
Array
(
[id] => 12509058
[patent_doc_number] => 10000469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-19
[patent_title] => Heat shock protein 70 (hsp-70) receptor ligands
[patent_app_type] => utility
[patent_app_number] => 15/128825
[patent_app_country] => US
[patent_app_date] => 2015-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 14
[patent_no_of_words] => 22056
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15128825
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/128825 | Heat shock protein 70 (hsp-70) receptor ligands | Mar 24, 2015 | Issued |
Array
(
[id] => 12115218
[patent_doc_number] => 09871214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-16
[patent_title] => 'Organic electroluminescent materials and devices'
[patent_app_type] => utility
[patent_app_number] => 14/665972
[patent_app_country] => US
[patent_app_date] => 2015-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9503
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14665972
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/665972 | Organic electroluminescent materials and devices | Mar 22, 2015 | Issued |
Array
(
[id] => 11799587
[patent_doc_number] => 09540376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Hexahydrodiazepinoquinolines carrying a substituted alkyl radical'
[patent_app_type] => utility
[patent_app_number] => 14/657916
[patent_app_country] => US
[patent_app_date] => 2015-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39287
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14657916
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/657916 | Hexahydrodiazepinoquinolines carrying a substituted alkyl radical | Mar 12, 2015 | Issued |
Array
(
[id] => 11395125
[patent_doc_number] => 20170015658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/125911
[patent_app_country] => US
[patent_app_date] => 2015-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 117450
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15125911
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/125911 | Hepatitis B core protein allosteric modulators | Mar 12, 2015 | Issued |
Array
(
[id] => 11401677
[patent_doc_number] => 20170022215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'Compounds for Eradicating or Inhibiting Proliferation of Cancer Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 15/124588
[patent_app_country] => US
[patent_app_date] => 2015-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12562
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15124588
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/124588 | Compounds for Eradicating or Inhibiting Proliferation of Cancer Stem Cells | Mar 10, 2015 | Abandoned |
Array
(
[id] => 11190413
[patent_doc_number] => 09421209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-23
[patent_title] => 'Kinase modulators'
[patent_app_type] => utility
[patent_app_number] => 14/642423
[patent_app_country] => US
[patent_app_date] => 2015-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 97204
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14642423
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/642423 | Kinase modulators | Mar 8, 2015 | Issued |